Real-time enrollment status for this chondrosarcoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 9:42 AM UTC
| NCT Number | NCT06127407 |
| Recruiting Status | Recruiting |
| Condition | Chondrosarcoma |
| Phase | PHASE3 |
| Target Enrollment | 136 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Servier Bio-Innovation LLC |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT06127407 is currently recruiting participants. This phase3 study for chondrosarcoma is actively seeking new participants at 22 locations across the United States. The study is sponsored by Servier Bio-Innovation LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06127407 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06127407 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.